Beta Bionics, Inc. (BBNX)Healthcare | Medical Devices | Irvine, United States | NasdaqGM
12.27 USD
-0.64
(-4.957%) ⇩
(April 21, 2026, 4 p.m.
EDT)
After hours: 12.65 +0.38 (3.097%) ⇧ (April 21, 2026, 6:10 p.m. EDT) Short-term: ★★☆☆☆ | Long-term: ★☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 19, 2026, 12:08 a.m. EDT
BBNX is statistically rated as a trap for long-term capital due to burning cash (-$50M operating run rate) while posting quarterly patient growth misses, despite a positive analyst consensus based on old/released 57% revenue growth data. The recent 10%+ price surge appears to be a 'long-squeeze' rebound rather than a fundamental turnaround, exacerbated by the lack of institutional interest in the options chain for any expiration beyond July 2026. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.216842 |
| AutoARIMA | 0.228762 |
| AutoETS | 0.228766 |
| AutoTheta | 0.230654 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 42% |
| H-stat | 22.90 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.233 |
| Excess Kurtosis | -1.24 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Revenue per Share | 2.474 |
| Market Cap | 546,772,032 |
| Forward P/E | -6.33 |
| Profit Margins | -73.02% |
| Website | https://www.betabionics.com |
As of April 19, 2026, 12:08 a.m. EDT: Options flow indicates a heavy disconnect in sentiment fading over time. In July 2026, there is a significant bullish skew, with massive Open Interest (Topology) concentrated significantly out-of-the-money (OTM) at strikes 15.0 and 35.0 on calls, suggesting a speculative bet on a massive spike. Conversely, put positioning is entirely In-The-Money (ITM) with low strikes (15.0 and 30.0), implying existing long holders are hedging downside rather than new capital betting on a crash. However, this bullish structure disappears completely in the October 2026 timeframe, where no put data exists and call Open Interest drops to near zero, indicating a lack of sustained conviction for the longer term.
| Attribute | Value |
|---|---|
| 52 Week Change | 0.24254096 |
| Address1 | 11 Hughes |
| All Time High | 32.71 |
| All Time Low | 8.8 |
| Ask | 12.31 |
| Ask Size | 4 |
| Average Analyst Rating | 1.6 - Buy |
| Average Daily Volume10 Day | 1,364,910 |
| Average Daily Volume3 Month | 1,152,673 |
| Average Volume | 1,152,673 |
| Average Volume10Days | 1,364,910 |
| Bid | 12.21 |
| Bid Size | 2 |
| Book Value | 6.483 |
| City | Irvine |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 12.27 |
| Current Ratio | 8.663 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 13.09 |
| Day Low | 11.84 |
| Display Name | Beta Bionics |
| Earnings Call Timestamp End | 1,776,803,400 |
| Earnings Call Timestamp Start | 1,776,803,400 |
| Earnings Timestamp | 1,776,801,600 |
| Earnings Timestamp End | 1,776,801,600 |
| Earnings Timestamp Start | 1,776,801,600 |
| Ebitda | -70,108,000 |
| Ebitda Margins | -0.69932 |
| Eps Current Year | -1.7725 |
| Eps Forward | -1.938 |
| Eps Trailing Twelve Months | -1.81 |
| Esg Populated | 0 |
| Exchange | NGM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 11.6994 |
| Fifty Day Average Change | 0.5706005 |
| Fifty Day Average Change Percent | 0.048771776 |
| Fifty Two Week Change Percent | 24.254095 |
| Fifty Two Week High | 32.71 |
| Fifty Two Week High Change | -20.439999 |
| Fifty Two Week High Change Percent | -0.6248853 |
| Fifty Two Week Low | 8.8 |
| Fifty Two Week Low Change | 3.4700003 |
| Fifty Two Week Low Change Percent | 0.3943182 |
| Fifty Two Week Range | 8.8 - 32.71 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,738,247,400,000 |
| Float Shares | 23,579,790 |
| Forward Eps | -1.938 |
| Forward P E | -6.3312697 |
| Free Cashflow | -40,903,624 |
| Full Exchange Name | NasdaqGM |
| Full Time Employees | 420 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.55398 |
| Gross Profits | 55,537,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.00968 |
| Held Percent Institutions | 1.09448 |
| Implied Shares Outstanding | 44,561,695 |
| Industry | Medical Devices |
| Industry Disp | Medical Devices |
| Industry Key | medical-devices |
| Ipo Expected Date | 2,025-01-30 |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of insulin-requiring people with diabetes. It offers iLet Bionic Pancreas, an insulin delivery device for the treatment of type 1 diabetes in adults and children six years of age and older. The company is also developing Patch Pump, an insulin pump that is designed to adhere directly to the skin and administer insulin without the need for tubing; Bihormonal iLet, which combines automated delivery of insulin and glucagon; and iLet to treat people with insulin-dependent type-2 diabetes. It has collaboration and license agreement with Xeris Pharmaceuticals, Inc. (Xeris) to develop and commercialize a pump-compatible glucagon formulation; and development and commercialization agreement with Abbott Diabetes Care Inc. to develop and commercialize an automated insulin delivery system. The company was incorporated in 2015 and is headquartered in Irvine, California. |
| Long Name | Beta Bionics, Inc. |
| Market | us_market |
| Market Cap | 546,772,032 |
| Market State | POST |
| Max Age | 86,400 |
| Message Board Id | finmb_365537151 |
| Net Income To Common | -73,200,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 575,291,482 |
| Number Of Analyst Opinions | 11 |
| Open | 13.03 |
| Operating Cashflow | -50,925,000 |
| Operating Margins | -0.71502 |
| Payout Ratio | 0.0 |
| Phone | 949 427 7785 |
| Post Market Change | 0.37999916 |
| Post Market Change Percent | 3.0969775 |
| Post Market Price | 12.65 |
| Post Market Time | 1,776,809,428 |
| Previous Close | 12.91 |
| Price Eps Current Year | -6.922426 |
| Price Hint | 2 |
| Price To Book | 1.8926424 |
| Price To Sales Trailing12 Months | 5.4540305 |
| Profit Margins | -0.73017 |
| Quick Ratio | 7.729 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | buy |
| Recommendation Mean | 1.63636 |
| Region | US |
| Regular Market Change | -0.6399994 |
| Regular Market Change Percent | -4.9573927 |
| Regular Market Day High | 13.09 |
| Regular Market Day Low | 11.84 |
| Regular Market Day Range | 11.84 - 13.09 |
| Regular Market Open | 13.03 |
| Regular Market Previous Close | 12.91 |
| Regular Market Price | 12.27 |
| Regular Market Time | 1,776,801,600 |
| Regular Market Volume | 977,131 |
| Return On Assets | -0.1873 |
| Return On Equity | -0.40261 |
| Revenue Per Share | 2.474 |
| Sand P52 Week Change | 0.34445214 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 44,561,695 |
| Shares Percent Shares Out | 0.1705 |
| Shares Short | 7,598,093 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 5,626,149 |
| Short Name | Beta Bionics, Inc. |
| Short Percent Of Float | 0.1713 |
| Short Ratio | 6.63 |
| Source Interval | 15 |
| State | CA |
| Symbol | BBNX |
| Target High Price | 32.0 |
| Target Low Price | 14.0 |
| Target Mean Price | 22.45455 |
| Target Median Price | 20.0 |
| Total Revenue | 100,251,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -1.81 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 19.246374 |
| Two Hundred Day Average Change | -6.9763737 |
| Two Hundred Day Average Change Percent | -0.3624773 |
| Type Disp | Equity |
| Volume | 977,131 |
| Website | https://www.betabionics.com |
| Zip | 92,618 |